Masimo Corp (NASDAQ:MASI) “Hold” Rating Maintained Today By Piper Jaffray; The TP is Set to $83.0

January 22, 2018 - By Winifred Garcia

 Masimo Corp (NASDAQ:MASI)

Investors sentiment increased to 1.18 in 2017 Q3. Its up 0.07, from 1.11 in 2017Q2. It improved, as 33 investors sold Masimo Corporation shares while 92 reduced holdings. 35 funds opened positions while 112 raised stakes. 42.22 million shares or 0.82% less from 42.57 million shares in 2017Q2 were reported.

Jacobs Levy Equity Mgmt Inc owns 138,028 shares. Prudential has invested 0.1% of its portfolio in Masimo Corporation (NASDAQ:MASI). Tennessee-based Weaver C Barksdale And Assoc has invested 0% in Masimo Corporation (NASDAQ:MASI). Los Angeles Management Equity Rech Incorporated owns 97,918 shares for 0.05% of their portfolio. Manufacturers Life Ins The holds 0.01% or 102,831 shares. Hbk Invs Lp holds 78,446 shares or 0.05% of its portfolio. Community State Bank Na reported 0% of its portfolio in Masimo Corporation (NASDAQ:MASI). Geode Capital Mngmt Limited Liability holds 654,186 shares. Oppenheimer Asset Management owns 7 shares. Mckinley Capital Ltd Liability Delaware reported 0.15% of its portfolio in Masimo Corporation (NASDAQ:MASI). Sawgrass Asset Mngmt Ltd Company has invested 0.02% in Masimo Corporation (NASDAQ:MASI). Apg Asset Mngmt Nv has invested 0.01% in Masimo Corporation (NASDAQ:MASI). Pitcairn holds 0.04% or 4,121 shares in its portfolio. Oakbrook Limited Co holds 3,250 shares. Nordea Invest Mgmt invested in 0.01% or 24,816 shares.

Since August 17, 2017, it had 0 insider purchases, and 2 selling transactions for $1.84 million activity. FITCH SANFORD also sold $959,750 worth of Masimo Corporation (NASDAQ:MASI) shares.

Masimo Corp (NASDAQ:MASI) Rating Reaffirmed

New York: In a research report made public on 31 October, Piper Jaffray maintained their “Hold” rating on Masimo Corp (NASDAQ:MASI) shares. They now have a $83.0 PT on the firm. Piper Jaffray’s target means a potential downside of -4.73 % from the company’s last stock close price.

Investors sentiment increased to 1.18 in 2017 Q3. Its up 0.07, from 1.11 in 2017Q2. It improved, as 33 investors sold Masimo Corporation shares while 92 reduced holdings. 35 funds opened positions while 112 raised stakes. 42.22 million shares or 0.82% less from 42.57 million shares in 2017Q2 were reported.

Jacobs Levy Equity Mgmt Inc owns 138,028 shares. Prudential has invested 0.1% of its portfolio in Masimo Corporation (NASDAQ:MASI). Tennessee-based Weaver C Barksdale And Assoc has invested 0% in Masimo Corporation (NASDAQ:MASI). Los Angeles Management Equity Rech Incorporated owns 97,918 shares for 0.05% of their portfolio. Manufacturers Life Ins The holds 0.01% or 102,831 shares. Hbk Invs Lp holds 78,446 shares or 0.05% of its portfolio. Community State Bank Na reported 0% of its portfolio in Masimo Corporation (NASDAQ:MASI). Geode Capital Mngmt Limited Liability holds 654,186 shares. Oppenheimer Asset Management owns 7 shares. Mckinley Capital Ltd Liability Delaware reported 0.15% of its portfolio in Masimo Corporation (NASDAQ:MASI). Sawgrass Asset Mngmt Ltd Company has invested 0.02% in Masimo Corporation (NASDAQ:MASI). Apg Asset Mngmt Nv has invested 0.01% in Masimo Corporation (NASDAQ:MASI). Pitcairn holds 0.04% or 4,121 shares in its portfolio. Oakbrook Limited Co holds 3,250 shares. Nordea Invest Mgmt invested in 0.01% or 24,816 shares.

Since August 17, 2017, it had 0 insider purchases, and 2 selling transactions for $1.84 million activity. FITCH SANFORD also sold $959,750 worth of Masimo Corporation (NASDAQ:MASI) shares.

Masimo Corporation (NASDAQ:MASI) Ratings Coverage

Among 8 analysts covering Masimo (NASDAQ:MASI), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Masimo has $10800 highest and $46 lowest target. $87.40’s average target is 0.32% above currents $87.12 stock price. Masimo had 14 analyst reports since August 5, 2015 according to SRatingsIntel. Piper Jaffray maintained it with “Hold” rating and $83.0 target in Tuesday, October 31 report. The rating was maintained by Roth Capital on Thursday, August 3 with “Buy”. The company was downgraded on Thursday, March 16 by PiperJaffray. The firm has “Buy” rating given on Monday, August 14 by BTIG Research. The firm has “Outperform” rating given on Wednesday, January 6 by Raymond James. Wedbush maintained Masimo Corporation (NASDAQ:MASI) on Monday, February 27 with “Outperform” rating. The rating was initiated by Stifel Nicolaus on Monday, July 10 with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 3 report. The rating was maintained by Piper Jaffray with “Hold” on Thursday, September 21. The stock of Masimo Corporation (NASDAQ:MASI) earned “Buy” rating by TH Capital on Wednesday, August 5.

The stock decreased 1.63% or $1.44 during the last trading session, reaching $87.12. About 109,111 shares traded. Masimo Corporation (NASDAQ:MASI) has risen 77.37% since January 22, 2017 and is uptrending. It has outperformed by 60.67% the S&P500.

Analysts await Masimo Corporation (NASDAQ:MASI) to report earnings on February, 13. They expect $0.61 earnings per share, up 19.61 % or $0.10 from last year’s $0.51 per share. MASI’s profit will be $31.52 million for 35.70 P/E if the $0.61 EPS becomes a reality. After $0.70 actual earnings per share reported by Masimo Corporation for the previous quarter, Wall Street now forecasts -12.86 % negative EPS growth.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $4.50 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 13.97 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

More news for Masimo Corporation (NASDAQ:MASI) were recently published by: Streetinsider.com, which released: “Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97” on January 09, 2018. Streetinsider.com‘s article titled: “Masimo Corp. (MASI) Reports CE Marking, Release of Oxygen Reserve Index …” and published on January 02, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: